glp 1 drugs novo nordisk launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry Novo Nordisk Finds Medicare Patients

A core gut microbiome in obese and lean twins

Quick Notables Collaborations, launches, and other tidbits to keep on your radar

Something went wrong while submitting the form

Breaking that medicine into smaller doses would make it hard to measure a consistent dose and increases your risk of infection (from reusing the syringe)

Semaglutide decreased the risk of a five-item secondary composite kidney outcome comprising decreased eGFR and A3 albuminuria [HR 0.78 (95% CI 0.630.96)] and a five-item composite outcome based on decreased eGFR and cardiovascular death [HR 0.82 (95% CI 0.690.97)]

If this is the case, she adds that its extremely important to be in contact with the patients therapist and/or psychiatrist